Splenic index score as a predictor of outcomes in metastatic non small cell lung cancer patients treated with immune checkpoint inhibitors

Abstract Introduction Immune checkpoint inhibitors (ICIs) targeting PD-1 and PD-L1 have emerged as promising treatments for advanced NSCLC patients without actionable mutations. However, predicting treatment response remains challenging, especially in second-line settings. Although PD-L1 is the only...

Descripción completa

Detalles Bibliográficos

Autores principales:	Volkan Aslan, Atiye Cenay Karabörk Kılıç, Nigar Rustamova Cennet, Talha alperen Yücel, Bediz kurt inci, Fatih gürler, Ahmet Özet, Nuriye Özdemir, Huseyin Koray Kilic, Ozan Yazıcı
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Nature Portfolio 2025-05-01
Colección:	Scientific Reports
Materias:	Immune checkpoint inhibitor Splenic volume mNSCLC Systemic inflammation NLR
Acceso en línea:	https://doi.org/10.1038/s41598-025-00708-w
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!